Tilray: A Global Leader

Gen3 Color Bar-01.png

Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis company.

A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.



Tilray's experience is unmatched worldwide. Our team of professionals on the ground in 7 countries serves thousands of patients and consumers around the globe. Our flagship cultivation facility is among the most advanced in the world.


Tilray is the first GMP-certified medical cannabis producer to supply cannabis flower and extracts. All of our products are produced with meticulous care to ensure the highest quality, consistency and purity for our patients.



We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.



Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.

Precisely formulated Products

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried flower. Each can be administered or consumed via a variety of methods.

We take a scientific approach to product development. Our product line focuses on active ingredients and standardized, well-defined preparations. We use formulations and delivery formats that are intended to allow for consistent and measured dosing, and we test all of our products for potency and purity. Each of our commercial products are developed with comprehensive analysis and thorough documentation, including stability profiles, certificates of analysis, monographs and drug master files. 

Global Gen III Group Image.png

Advancing Cannabinoid Science

For the therapeutic value and risks of cannabinoid-based medicines to be fully understood, Tilray believes it is critical to evolve current scientific understanding of the field. Our clinical research program is designed with that in mind. 

Participation in clinical trials is a differentiating element of our research and development program. We have developed techniques that achieve clinical grade isolates in order to facilitate participation in clinical trials conducted by select research partners at world-leading hospitals and universities. 

Facility Tour: Tilray Nanaimo 


Production Process

Tilray choreographs a complex series of cutting-edge processes to deliver unparalleled product to its patients. From cultivation to shipping, Tilray's team brings precision, professionalism and care to each stage of the process.

TR Process Diagram.jpg

Global Reach

As laws and regulations regarding cannabis and hemp evolve in different jurisdictions, we are actively seeking to expand our operations around the world.

TR Global Map_v2.png


Tilray was the first company to legally export medical cannabis from North America to Australia and New Zealand. Today, Tilray is one of the leading providers of medical cannabis in Australia and New Zealand for commercial, compassionate access and research purposes.


Tilray was one of the first companies to be licensed to produce medical cannabis in Canada. Today, Tilray is the country's leading scientifically rigorous provider of medical cannabis, supplying tens of thousands of patients in every province with consistent access to whole flower, milled blends and oils.



Tilray was the first company to legally export medical cannabis products from North America to Europe. Tilray also has a cultivation license from the Government of Portugal to produce products for the EU market. Tilray products are currently available at pharmacies in countries throughout the EU.


Tilray Latin America imports, produces and distributes Tilray branded medical cannabis products in Chile. Tilray Latin America will act as a hub to distribute Tilray products throughout Latin America, strengthening the company’s presence in the region.


Tilray's diverse management team of industry-leading experts includes PhD research scientists, master horticulturists, engineers, and patient advocates.

Board of Directors

Brendan Kennedy: CEO, Tilray

Brendan Kennedy is CEO of Tilray, a global pioneer in cannabis research, production, and distribution. Brendan brings a strong background of entrepreneurship and hands-on business experience at the forefront of the venture backed-business community to Tilray. As a member of the founding team at SVB Analytics, a non-bank affiliate of Silicon Valley Bank, he managed an international team that rendered valuation opinions for emerging growth technology, life science and venture capital companies. He is also the co-founder of Privateer Holdings, the world's first private equity firm to invest exclusively in legal cannabis, which has raised $200+ million to build a global portfolio of leading cannabis businesses. He holds a B.A. from the University of California, Berkeley; an M.S. from the University of Washington; and an M.B.A. from the Yale School of Management.

Christine St.Clare: Ret. Partner, KPMG

Christine St.Clare founded St.Clare Advisors, LLC in September 2010 and currently serves as its President. Prior to founding her own firm, Christine was a partner at KPMG LLP, where she was an Audit Partner from 1986 to 2005 and Advisory Partner from 2006 to 2010. During her time at KPMG, Christine served as Lead Audit Partner for some of the firm’s largest retail clients and served a four-year term on KPMG’s Board of Directors. She currently is an Independent Director of Fibrocell Science, Inc., and AquaBounty Technologies, Inc. and was an Independent Director for AVINTIV, Inc.  (formerly known as Polymer Group, Inc.) prior to the sale of the company.

Rebekah Dopp: Principal, Google

Rebekah Dopp is Principal, News and Local Media – Global Partnerships at Google. She joined the company in September 2016 as Head of Local TV Partnerships for YouTube TV. Prior to joining Google, Rebekah was Senior Vice President, Advanced Services for CBS Corporation (CBS). She began her media career at Home Box Office, Inc. (HBO) where she spent 14 years in leadership positions in technology and distribution, culminating in her role as Vice President, Global Technology Business Management. Rebekah has led global teams negotiating complex agreements with domestic and international technology partners and affiliates and was on the launch teams for streaming TV services HBO GO, CBS All Access, and YouTube TV.

Scotty Greenwood: CEO, Canadian American Business Council

Maryscott “Scotty” Greenwood currently serves as CEO of the Canadian American Business Council and as Partner and Managing Director, U.S. for Crestview Strategy. Prior to this, Scotty served as Principal at Dentons U.S. LLP (Dentons) in the firm’s Public Policy Group and as co-leader of the practice’s Advocacy and Government Affairs team. Immediately before joining Dentons in 2001, Scotty spent four years as chief of staff of the U.S. Embassy in Canada as a Presidential appointee. From 1993 to 1997, Scotty was director of intergovernmental affairs for the City of Atlanta, handling state and federal relations, including working on several projects related to the 1996 Centennial Olympic Games.

Michael Auerbach: Senior Vice President, Albright Stonebridge Group

Michael Auerbach currently serves as Senior Vice President at Albright Stonebridge Group (ASG) and General Partner at Subversive Capital.  Prior to joining ASG, he served as a Vice President at global risk consultancy Control Risks. A dot-com bubble veteran, Michael started his career in technology, running Panopticon Inc., a VC incubator concentrating on internet and mobile technology. Michael has held senior positions at the Center for American Progress and The Century Foundation, where he concentrated on issues related to U.S. Foreign Policy, National Security, and Conflict Resolution. 

Medical Advisory Board

Orrin Devinsky, MD, Chairman

Orrin Devinsky, MD, Chairman, is Director of the Comprehensive Epilepsy Center at the NYU Langone Medical Center. His research interests include the use of cannabinoids and other medications to treat a variety of epilepsy syndromes. He has served on the Board of Directors of the American Epilepsy Society, the Epilepsy Foundation and the Epilepsy Therapy Project, as well as the Scientific Advisory Boards of numerous disease organization. Dr. Devinsky has been an invited speaker at international epilepsy and neurology conferences for more than 20 years, and has authored over 400 peer-reviewed scientific articles and 20 books and monographs.

Abraham Chachoua, MD

Abraham Chachoua, MD, is Associate Director of Cancer Services at the NYU Langone Perlmutter Cancer Center and the Jay and Isabel Fine Professor of Oncology at the NYU Langone Department of Medicine. He specializes in the treatment of cancers that affect the lungs and chest. He has been involved in a number of clinical trials for the treatment of non-small cell lung cancer. Dr. Chachoua has a particular interest in the study of novel targeted therapies and earlier intervention in disease, integrating multiple modalities for the treatment of locally advanced lung cancer.

Elizabeth K. Hale, MD

Elizabeth K. Hale, MD, is a Clinical Associate Professor of Dermatology at NYU Langone Medical Center and the co-Founder of CompleteSkinMD in New York City. She specializes in laser surgery and cosmetic dermatology. Dr. Hale has extensive experience in the field of skin cancer and is a senior vice president of the Skin Cancer Foundation. She has been named a “Best Doctor in Dermatology” by New York Magazine and a “Super Doctor” by the New York Times for the past five years. Dr. Hale has been an invited lecturer at international conferences focused on skin cancer and its treatment. Dr. Hale has authored over 40 peer-reviewed articles and more than 10 textbooks and chapters.

Catherine Lord, PhD

Catherine Lord, PhD, is Professor of Psychology in Psychiatry and founding Director of the Center for Autism and the Developing Brain (CADB), a collaborative program between New York-Presbyterian Hospital, Weill Cornell Medicine, and Columbia University College of Physicians and Surgeons in partnership with New York Collaborates for Autism. She is internationally recognized for her work in longitudinal studies of children with autism as well as for her role in developing the autism diagnostic instruments used in both practice and in research worldwide today.


International Advisory Board

Governor Howard Dean

Governor Howard Dean is a former Democratic National Committee (DNC) Chairman, presidential candidate, six-term Governor of Vermont, and physician. Gov. Dean is also the founder of Democracy for America, a lecturer at Yale University and a strategic consultant for the global law firm Dentons.

Michael Steele

Michael Steele made history when he was elected Lieutenant Governor of Maryland in 2003, as the first African American elected to statewide office; and again, with his subsequent chairmanship of the Republican National Committee (RNC). Under Mr. Steele’s leadership the RNC broke fundraising records and led Republicans to win 63 House seats in 2010, the biggest pick-up since 1938. Mr. Steele is an accomplished author and media commentator

The Honourable Lloyd Axworthy P.C., C.C., O.M.

The Honourable Lloyd Axworthy P.C., C.C., O.M., is the chair of the World Refugee Council and one of Canada’s leading voices on global migration and refugee protection. Throughout his 27-year political career, he served as Canada’s Minister of Foreign Affairs and Minister of Employment and Immigration, among other postings.

Joschka Fischer

Joschka Fischer served as Foreign Minister and Vice Chancellor of the Federal Republic of Germany. He is a member of the Executive Board of the European Council on Foreign Relations. Mr. Fischer also currently serves as Managing Partner of Joschka Fischer & Company, a global strategy firm, where he advises clients on issues relating to Germany and the European Union.

Jaime Gama

Jaime Gama is the longest-serving Portuguese Minister of Foreign Affairs. Over a distinguished career in public policy, Mr. Gama served as Minister of Foreign Affairs, Minister of Home Affairs, Minister of Defense, and Minister of State. He was a member of the Government in 2001 when Portugal approved its decriminalization and harm reduction drug policy. He was elected Member of Parliament and served as the Speaker of the Parliament. Mr. Gama serves as the chairman of a bank and of a private foundation.

The Honourable Alexander John Gosse Downer, AC

The Honourable Alexander John Gosse Downer, AC, was the longest-serving Minister for Foreign Affairs in Australia in history, holding his position for ten years. He also served has High Commissioner to the United Kingdom. Mr. Downer was a diplomat in the Department of Foreign Affairs, serving in the Australian Mission to the European Union, the Australian Representation to the North Atlantic Treaty Organization (NATO) and at Australian embassies in Belgium and Luxembourg.

Rt Hon Sir Donald McKinnon, ONZ, GCVO

Rt Hon Sir Donald McKinnon, ONZ, GCVO, was New Zealand’s longest serving Minister of Foreign Affairs and Trade and held the portfolios of Disarmament and Arms Control, Veteran’s Affairs, War Pensions, and Pacific Island Affairs. Mr. McKinnon served as Deputy Prime Minister, Leader of the House and was appointed a member of Her Majesty’s Privy Council. He was nominated for the Nobel Peace Prize for his work in initiating and overseeing the ceasefire between Bougainvilleans and the Papua New Guinea Government in 1997.

James O’Brien

James O’Brien served two U.S. administrations as Special Presidential Envoy. Mr. O’Brien has been Senior Advisor to the U.S. Secretary of State and served as the Principal Deputy Director of Policy Planning at the State Department. Mr. O’Brien currently serves as Vice Chair of Albright Stonebridge Group (ASG) and heads up the firm’s practice in Europe.

Dr. Lorna Marsden

Dr. Lorna Marsden is a former Canadian Senator from Ontario who was appointed to the position by former Prime Minister Pierre Trudeau. She served in the Senate for eight and a half years, where she was a member of the Standing Committee on National Finance and chairwoman of the Standing Committee on Social Affairs, Science and Technology. Dr. Marsden also served as President and Vice-Chancellor of York University and President and Vice-Chancellor of Wilfrid Laurier University in Waterloo, Ontario.

Tilray News


Tilray in the Press